Effects of transforming growth factor β-1 on growth-regulatory genes in tumour-derived human oral keratinocytes

British Journal of Cancer

Volumn 72, Issue 4, 1995, Pages 922-927

  Paterson, I C ^a   Patel, V ^a   Sandy, J R ^a   Prime, S S ^a   Yeudall, W A ^a  

^a BRISTOL DENTAL HOSPITAL   (United Kingdom)

Author keywords

C myc; Junb; Keratinocytes; P53; Rb phosphorylation; Transforming growth factor

Indexed keywords

MESSENGER RNA; PROTEIN P53; RETINOBLASTOMA PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CELL LINE; CONTROLLED STUDY; GENE AMPLIFICATION; GENE EXPRESSION; GROWTH REGULATION; HUMAN; HUMAN CELL; KERATINOCYTE; MESSENGER RNA SYNTHESIS; ONCOGENE; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

CARCINOMA, SQUAMOUS CELL; CELLS, CULTURED; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, JUN; GENES, MYC; GENES, P53; HUMAN; KERATINOCYTES; MOUTH NEOPLASMS; PHOSPHORYLATION; RETINOBLASTOMA PROTEIN; SUPPORT, NON-U.S. GOV'T; TRANSFORMING GROWTH FACTOR BETA;

EID: 0028871322     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1995.434     Document Type: Article

References (39)

1. ALITALO K, KOSKINEN P, MAKELA TP, SASKELA K, SISTONEN L, AND WINQVIST R. (1987). myc oncogenes: activation and amplification. Biochim. Biophys. Acta, 907, 1–32.
2. CHEN RH, EBNER R, AND DERYNCK R. (1993). Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF- β1 activities. Science, 260, 1335–1338.
3. CHOMCZYNSKI P, AND SACCHI N. (1987). Single-step method of RNA isolation by acid guandinium thiocynate phenol-chloroform extraction. Ann. Biochem., 162, 156–159.
4. COFFEY RJ, BASCOM CC, SIPES NJ, GRAVESD-EAL R, WEISSMAN BE, AND MOSES HL. (1988). Selective inhibition of growth-related gene expression in murine keratinocytes by transforming growth factor β. Mol. Cell. Biol., 8, 3088–3093.
5. EWEN ME, OLIVER CJ, SLUSS HK, MILLER SJ, AND PEEPER DS. (1995). p53-dependent repression of CDK4 translation in TGF- β -induced G, cell-cycle arrest. Genes Dev., 9, 204–217.
6. FYNAN TM, AND REISS M. (1993). Resistance to inhibition of cell growth by transforming growth factor- β and its role in oncogenesis. Crit. Rev. Oncogenesis, 4, 493–540.
7. GAME SM, HUELSEN A, PATEL V, DONNELLY M, YEUDALL WA, STONE A, FUSENIG NE, AND PRIME SS. (1992). Progressive abrogation of TGF- β 1 and EGF growth control is associated with tumour progression in ray-transfected human keratinocytes. Int. J. Cancer, 52, 461–470.
8. GERWIN BI, SPILLARE E, FORRESTIER K, LEHMAN TA, KISPERT J, WELSH JA, PFEIFER AMA, LECHNER JF, BAKER SJ, VOGELSTEIN B, AND HARRIS CC. (1992). Mutant p53 can induce tumorigenic conversion of human bronchial epithelial cells and reduce their responsiveness to a negative growth factor, transforming growth factor β 1. Proc. Natl Acad. Sci. USA, 89, 2759–2763.
9. 1 growth arrest by transforming growth factor β 1 requires cellular ras activity. J. Biol. Chem., 269, 21448–21452.
10. HUNTER T, AND PINES J. (1994). Cyclins and cancer II: Cyclin D and CDK inhibitors come of age. Cell, 79, 573–582.
11. KIMCHI A, WANG XF, WEINBERG RA, CHEIFETZ S, AND MASSAGNE J. (1988). Absence of TGF-β receptors and growth inhibitory responses in retinoblastoma cells. Science, 240, 196–199.
12. KOIKE M, ISHINO K, HUH N, AND KUROKI T. (1994). Growth inhibition of SV40-transformed human keratinocytes by TGF-β S is not linked to dephosphorylation of the Rb gene product. Biochem. Biophys. Res. Common., 201, 673–681.
13. KREIG P, AMTMANN E, AND SUAER G. (1983). The simultaneous extraction of high molecular weight DNA and of RNA from solid tumors. Ann. Biochem., 134, 288–294.
14. LAIHO M, DECAPRIO JA, LUDLOW JW, LIVINGSTON DM, AND MASSAGUE J. (1990a). Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation. Cell, 62, 175–185.
15. LAIHO M, WEIS FMB, AND MASSAGUE J. (1990b). Concomitant loss of transforming growth factor (TGF)-0 receptors types I and II in TGF-β resistant cell mutants implicates both receptor types in signal transduction. J. Biol. Chem., 265, 18518–18524.
16. LAIHO M, WIES FMB, BOYD FT, IGNOTZ RA, AND MASSAGNE J. (1991). Responsiveness to transforming growth factor-β (TGF-β) restored by genetic complementation between cells defective in TGF-β receptors I and II. J. Biol. Chem., 266, 9108–9112.
17. LANDESMAN Y, PAGANO M, DRAETTA G, FUSENIG NE, AND KIMCHI A. (1992). Modifications of cell cycle controlling nuclear proteins by transforming growth factor 0 in the HaCaT keratinocyte cell line. Oncogene, 7, 1661–1665.
18. MANNING AM, WILLIAMS AC, GAME SM, AND PARASKEVA C.(1991). Differential sensitivity of human colonic adenoma and carcinoma cells to transforming growth factor β (TGF-β): Conversion of an adenoma cell line to a tumorigenic phenotype is accompanied by a reduced response to the inhibitory effects of TGF-β. Oncogene, 6, 1471–1476.
19. MASSAGUE J. (1992). Receptors for the TGF-β family. Cell, 69, 1067–1070.
20. MATLASHEWSKI GJ, TUCK S, PIM D, LAMB P, SCHNEIDER J, AND CRAWFORD LV. (1987). Primary structure polymorphism at amino-acid residue-72 of human p53. Mol. Cell. Biol., 7, 961–963.
21. MISSERO C, CAJAL SRY, AND DOTTO GP. (1991). Escape from transforming growth factor β control and oncogene cooperation in skin tumour development. Proc. Natl Acad. Sci. USA, 88, 9613–9617.
22. MUNGER K, PIETENPOL JA, PITTELKOW MR, HOLT JT, AND MOSES HL. (1992). Transforming growth factor β 1 regulation of c-myc expression, pRB phosphorylation, and cell cycle progression in keratinocytes. Cell Growth Differ., 3, 291–298.
23. Cipl in muscle and other terminally differentiating cells. Science, 267, 1024–1027.
24. PARKINSON EK, AND YEUDALL WA. (1991). The culture of primary tumours from human epidermis. In Primary Cultures for Human tumour Biopsies: a Handbook. Masters J (ed.), pp. 187-197. Kluwer: Boston.
25. PATEL V, YEUDALL WA, GARDNER A, MUTLU S, SCULLY C, AND PRIME SS. (1993). Consistent chromosomal anomalies in keratinocyte cell lines derived from untreated malignant lesions of the oral cavity. Genes. Chrom. Cancer, 7, 109–115.
26. PIETENPOL JA, HOLT JT, STEIN RW, AND MOSES HL. (1990a). Transforming growth factor- β suppression of c-myc gene transcription: role in inhibition of keratinocyte proliferation. Proc. Natl Acad. Sci. USA., 87, 3758–3762.
27. PIETENPOL JA, STEIN RW, MORAN P, YACIUK R, SCHLEGEL R, LYONS RM, PITTELKOW MR, MUNGER K, HOWLEY PM, AND MOSES HL. (1990b). TGF- β 1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains. Cell, 61, 777–785.
28. PRIME SS, HIXON SVR, CRANE IJ, STONE A, MATTHEWS JB, MAITLAND NJ, REMNANT L, POWELL SK, GAME SM, AND SCULLY C. (1990). The behaviour of human oral squamous cell carcinoma in cell culture. J. Pathol., 160, 259–269.
29. PRIME SS, MATTHEWS JB, PATEL V, GAME SM, DONNELLY M, STONE AS, PATERSON IC, SANDY JR, AND YEUDALL WA. TGF- β receptor regulation mediates the response to exogenous ligand but is independent of the degree of cellular differentiation in human oral keratinocytes. Int. J. Cancer, 56, 406–412.
30. SEGARINI PR, ROSEN DM, AND SEYEDIN SM. (1989). Binding of TGF- β to cell surface proteins varies with cell type. Mol. Endocrinol., 3, 261–272.
31. SU HUANG HJ, YEE JK, SHEW JY, CHEN PL, BROOKSTEIN R, FRIEDMAN T, LEE EYHP, AND LEE WH. (1988). Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. Science, 242, 1563–1566.
32. WAGA S, HANNON GJ, BEACH D, AND STILLMAN B. (1994). The p21 cyclin-dependent kinase inhibitor directly controls DNA replication with PCNA. Nature, 369, 574–578.
33. WEISER R, ATTISANO L, WRANA JL, AND MASSAGUE J. (1993). Signaling activity of transforming growth factor P type II receptors lacking specific domains in the cytoplasmic region. Mol. Cell. Biol., 13, 7239–7247.
34. WRANA JL, ATTISANO L, CARCAMO J, ZENTELLA A, DOODY J, LAIHO M, WANG X-F, AND MASSAGUE J. (1992). TGF- β signals through a heteromeric protein kinase receptor complex. Cell, 71, 1003–1014.
35. WRANA JL, ATTISANO L, WEISER R, VENTURA F, AND MASSAGUE J. (1994). Mechanism of activation of the TGF-0 receptor. Nature, 370, 341–347.
36. YAN Z, WINAWER S, AND FRIEDMAN E. (1994). Two different signal transduction pathways can be activated by transforming growth factor- β 1 in epithelial cells. J. Biol. Chem., 269, 13231–13237.
37. YEUDALL WA, TORRANCE LK, ELSEGOOD KA, SPEIGHT P, SCULLY C, AND PRIME SS. (1993). ras gene point mutation is a rare event in premalignant and malignant lesions of the oral cavity. Oral Oncol. Eur. J. Cancer, 28B, 63–68.
38. YEUDALL WA, PATERSON IC, PATEL V, AND PRIME SS. (1995). Presence of human papillomavirus sequences in tumour-derived human oral keratinocytes expressing mutant p53 protein. Oral Oncol. Eur J. Cancer, 31B, 136–143.
39. ZENTELLA A, WEIS, FMB, RALPH DA, LAIHO M, AND MASSAGUE J.(1992). Early gene responses to transforming growth factor- β in cells lacking growth-suppressive RB function. Mol. Cell. Biol., 11, 4952–4958.